Lymphotoxin Beta-Activated LTBR/NIK/RELB Axis Drives Proliferation in Cholangiocarcinoma
Kaiyu Xu,Annika Kessler,Federico Nichetti,Paula Hoffmeister-Wittmann,Anna-Lena Scherr,Luisa Nader,Eblina Kelmendi,Nathalie Schmitt,Maximilian Schwab,Maria Garcia-Beccaria,Benjamin Sobol,Osama Azzam Nieto, Hanna Isele,Ulrike Gaertner, Nuria Vaquero-Siguero, Julia Volk,Felix Korell,Andreas Mock,Danijela Heide,Pierluigi Ramadori,Benedicte Lenoir,Thomas Albrecht,Jennifer Huellein,Dirk Jaeger,Stefan Froehling,Christoph Springfeld,Rene Jackstadt,Mathias Heikenwaelder,Michael T. Dill,Stephanie Roessler,Benjamin Goeppert,Bruno C. Koehler LIVER INTERNATIONAL（2024）
Key words
cholangiocarcinoma,LTB,NF-kappa B,NIK,RelB,small molecule inhibitor B022
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper